• OPEN AN ACCOUNT
Indian Indices
Nifty
25,758.00 -81.65
(-0.32%)
Sensex
84,725.31 334.04
( 0.40%)
Bank Nifty
58,960.40 -261.95
( -0.44%)
Nifty IT
37,789.90 -340.70
( -0.89%)
Global Indices
Nasdaq
48,074.52 493.22
(1.04%)
Dow Jones
6,906.36 44.85
(0.65%)
Hang Seng
50,166.54 -436.26
(-0.86%)
Nikkei 225
9,661.39 19.38
(0.20%)
Forex
USD-INR
89.93 -0.16
(-0.18%)
EUR-INR
104.64 -0.26
(-0.25%)
GBP-INR
119.76 -0.28
(-0.23%)
JPY-INR
0.58 0.00
(-0.73%)

Corporate Actions - Latest Board Meetings

EQUITY - MARKET SCREENER

Company Name Date Purpose
Addi Industries 11-Dec-25 Addi Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve Board meeting for changes in the Board of Directors of the Company.
Dugar Housing 11-Dec-25 Dugar Housing Developments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve Raising of funds through issue of Equity Shares through Preferential Issue
Suryo Foods 11-Dec-25 Suryo Foods & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve In furtherance to our intimation dated 03.12.2025 regarding the outcome of the meeting of the Board of Directors of Suryo Foods & Industries Limited and pursuant to Regulation 29 and other applicable provisions of SEBI (LODR) Regulations 2015 this is to inform you that the meeting of the Board of our Company is scheduled to be held on Thursday 11.12.2025 to consider inter-alia the following: 1.Proposal of fund raising by way of issue of equity shares or other securities of the Company through a rights issue and/or any other permissible mode as may be permitted under applicable law subject to such regulatory/ statutory approvals as may be required. 2.Approval of the Draft Letter of Offer for the Rights Issue. 3.Constitution of a Rights Issue Committee for the purpose of giving effect to the Rights Issue. 4.Appointment of Registrar to the Issue Banker to Issue Monitoring Agency and all other intermediaries advisors and agencies necessary for the Rights Issue.
Solitaire Mach. 11-Dec-25 Solitaire Machine Tools Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve Apropos Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the company is scheduled to be held on Thursday 11th December 2025 at 11.00 a.m. at the Registered Office of the Company situated at A-24/25 Krishna Industrial Estate Near B.I.D.C. Gorwa Vadodara- 390016 Gujarat India inter alia to consider and appoint Ms. Reshma Kiri as a Company Secretary and Compliance Officer. Kindly take the same on your record & oblige.
Ashiana Housing 11-Dec-25 Ashiana Housing Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve the raising of funds through issue of Unsecured Non-Convertible Debentures on private placement basis.
Hemo Organic 11-Dec-25 Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve 1. Proposal for raising of funds by way of issue of Equity shares and/or Convertible warrants on preferential basis. 2. To fix date place and time for conducting Extra-Ordinary General Meeting of the Company for the above-mentioned agenda and to approve the Notice for the EGM. 3. Any other agenda matter to be discussed with the permission of Chairman of the Board Meeting
iStreet Network 11-Dec-25 Istreet Network Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve the agenda attached for the meeting
Indrayani Biotec 11-Dec-25 Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve the unaudited financial (Standalone and Consolidated) results for the Quarter and half year ended 30th September 2025
IIFL Finance 11-Dec-25 Inter alia, to consider and approve: Fund Raising through issuance of Non-Convertible Debentures on private placement basis
Novelix Pharma. 11-Dec-25 Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve 1) To consider and if thought fit approve the issuance of securities of the Company on a preferential basis in accordance with the Companies Act 2013 read with the rules notified thereunder each as amended and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and such other acts rules and regulations as may be applicable subject to any regulatory/ statutory approvals as may be required and the approval of the shareholders of the Company. 2) To adopt and approve the Draft Notice of Extra Ordinary General Meeting of the Company. 3) To fix the day date time and venue of Extra Ordinary General Meeting of the Company. 4) To appoint Scrutinizer for conducting E- voting process for Extra Ordinary General Meeting. 5) Any other Matter with the permission of the chair.
<< < 1 2 > >>